Journal article
An interbacterial DNA deaminase toxin directly mutagenizes surviving target populations
eLife, Vol.10, e62967
01/01/2021
DOI: 10.7554/eLife.62967
PMCID: PMC7901873
PMID: 33448264
Abstract
When bacterial cells come in contact, antagonism mediated by the delivery of toxins frequently ensues. The potential for such encounters to have long-term beneficial consequences in recipient cells has not been investigated. Here, we examined the effects of intoxication by DddA, a cytosine deaminase delivered via the type VI secretion system (T6SS) of Burkholderia cenocepacia. Despite its killing potential, we observed that several bacterial species resist DddA and instead accumulate mutations. These mutations can lead to the acquisition of antibiotic resistance, indicating that even in the absence of killing, interbacterial antagonism can have profound consequences on target populations. Investigation of additional toxins from the deaminase superfamily revealed that mutagenic activity is a common feature of these proteins, including a representative we show targets single-stranded DNA and displays a markedly divergent structure. Our findings suggest that a surprising consequence of antagonistic interactions between bacteria could be the promotion of adaptation via the action of directly mutagenic toxins.
Details
- Title: Subtitle
- An interbacterial DNA deaminase toxin directly mutagenizes surviving target populations
- Creators
- Marcos H. de MoraesFoSheng HsuDean HuangDustin E BoschJun ZengMatthew C. RadeyNoah SimonHannah E. LedvinaJacob P FrickPaul A. WigginsS. Brook PetersonJoseph D. Mougous
- Resource Type
- Journal article
- Publication Details
- eLife, Vol.10, e62967
- DOI
- 10.7554/eLife.62967
- PMID
- 33448264
- PMCID
- PMC7901873
- NLM abbreviation
- Elife
- eISSN
- 2050-084X
- Publisher
- eLife Sciences Publications, Ltd
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: GM128191; DOI: 10.13039/100000002, name: National Institutes of Health, award: AI080609; DOI: 10.13039/100000011, name: Howard Hughes Medical Institute; DOI: 10.13039/100000897, name: Cystic Fibrosis Foundation, award: DEMORA18F0; DOI: 10.13039/100000861, name: Burroughs Wellcome Fund; DOI: 10.13039/100000002, name: National Institutes of Health, award: DK089507; DOI: 10.13039/100000897, name: Cystic Fibrosis Foundation, award: SINGH19RO
- Language
- English
- Date published
- 01/01/2021
- Academic Unit
- Pathology
- Record Identifier
- 9984530266202771
Metrics
31 Record Views